Wegovy Tablets (Oral Semaglutide)
Interested in a tablet-based weight loss treatment? Wegovy tablets (oral semaglutide) deliver proven GLP-1 appetite suppression in a convenient daily oral pill — eliminating needles while helping you control hunger, reduce food noise, and maintain sustainable weight loss.
Wegovy Tablet Titration Tiers
New to Wegovy tablets? All new patients begin on 1.5mg daily for Month 1.
Recommended for all new oral semaglutide patients (Month 1 / Weeks 1–4)
Wegovy tablets are purchased at cost price directly from the pharmacy, facilitated by Smiths Medical Group.
What are Wegovy Tablets?
Wegovy tablets contain oral semaglutide, providing an effective daily oral treatment option for medical weight management.
Active Ingredient
Contains oral semaglutide, acting on GLP-1 pathways in the body to control appetite and calorie intake.
How It Works
Increases feelings of satiety, delays gastric emptying, and significantly curbs food cravings.
Daily Administration
Taken once daily on an empty stomach in the morning with a small sip of water.
Suitability
Suitable for adults with obesity (BMI ≥ 30) or overweight adults (BMI ≥ 27) with health conditions.
Proven Efficacy
Delivers clinically significant weight reduction comparable to injectable GLP-1 therapies when paired with guidance.
Safety & Tolerability
Mild digestive adjustment is common. Gradual monthly dose titration minimizes unwanted side effects.
Wegovy Tablets Dosing Schedule
Wegovy tablets are taken once daily. We follow a structured monthly escalation schedule to gradually build dose strength while ensuring gastrointestinal comfort.
Month 1
Start with 1.5mg daily to allow your body to adapt smoothly to oral semaglutide.
Month 2
Escalate to 4mg daily to enhance appetite regulation and food noise reduction.
Month 3
Increase to 9mg daily to support continuous weight loss progression.
Month 4+
Reach the maximum licensed 25mg daily maintenance dose for long-term weight management.
Administration Instructions for Maximum Absorption:
Oral semaglutide requires strict morning administration on an empty stomach with a small sip of plain water (up to 120ml). Wait at least 30 minutes before eating, drinking coffee or tea, or taking other oral medications. Following these steps ensures proper therapeutic absorption.
Targeted Blood Panels for Optimised Weight Management
At Smiths Medical Group, we provide an enhanced level of clinical diligence. By incorporating comprehensive blood analysis before and during your weight loss journey, we ensure your treatment is precisely tailored, safe, and protective of your long-term metabolic health.
Weight Loss Commencement Profile
Conducted prior to starting weight management therapy to establish your baseline organ function, screen for underlying metabolic or hormonal factors, and ensure prescribing suitability.
What It Evaluates:
- Liver & Kidney Function: Confirms healthy organ clearance for weight loss medications.
- Full Glycaemic Assessment (HbA1c & Fasting Blood Sugar): Screens for undiagnosed insulin resistance or pre-diabetes.
- Comprehensive Lipid Profile: Evaluates cholesterol markers to track cardiovascular improvements over time.
- Thyroid Function (TSH & Free T4): Rules out underlying thyroid dysfunction that can suppress metabolic rate.
Weight Loss Monitoring Profile
Recommended periodically during active weight loss to track metabolic response, verify nutritional balance, and adjust your treatment parameters with objective clinical data.
Key Monitoring Clinical Benefits:
- Nutritional & Micronutrient Status: Checks key micronutrient and vitamin levels as dietary intake reduces.
- Metabolic Trend Tracking: Measures progress in blood glucose, triglycerides, and liver enzymes during weight reduction.
- Dose Optimisation: Informs decisions on dosage titration to ensure efficacy while minimising unwanted side effects.
- Physician & ANP Oversight: Provides clear objective markers for review by Matthew Smith (ANP) and Dr Iqbal (Medical Director).
Why Blood Monitoring Provides a Superior Standard of Care
Standard online weight loss services often issue prescriptions based solely on online questionnaires without objective health data. At Smiths Medical Group, offering dedicated Commencement and Monitoring Blood Profiles elevates your care to a premium clinical standard.
Identifies pre-existing organ or metabolic conditions before starting active medication.
Provides clear, objective biomarker metrics demonstrating internal health improvements alongside scale weight.
Conducted with expert review from Advanced Nurse Practitioner Matthew Smith and Medical Director Dr Iqbal.
Wegovy Tablets FAQs
Answered by Matthew Smith, Advanced Nurse Practitioner.
Start Your Wegovy Tablets Treatment Plan
Book your initial £50 consultation with Matthew Smith, Advanced Nurse Practitioner, to establish eligibility, complete baseline health checks, and start your oral semaglutide plan.
Smiths Medical Group Ltd